Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03770169 · ClinicalTrials.gov registry record

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

A clinical trial of Vulvodynia, sponsored by Ipsen.

Completed
Registry status
20
Enrollment target
4
Study locations

NCT03770169 is a study of Vulvodynia that has completed, run by Ipsen. The registered enrollment target is 20 participants, below the 136-participant average among 9 other Vulvodynia trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03770169, a study of Vulvodynia, has completed, sponsored by Ipsen.

COMPLETED
Registry status
20 participants
Enrollment target
4
Study locations

Study Summary

The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia

Conditions Studied

Vulvodynia

Study Locations (4)

California

  • San Diego Sexual Medicine - San Diego

District of Columbia

  • Center for Vulvovaginal Disorders - Washington D.C.

Nebraska

  • Omaha OB-GYN Associates, PC - Omaha

New York

  • The Center for Vulvovaginal Disorders - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-02-18
Est. Completion 2019-09-19

Sponsor

Ipsen

85 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03770169

The ClinicalTrials.gov registry entry for NCT03770169 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 9 other Vulvodynia trials with a reported enrollment target (85% lower). The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vulvodynia appearing as the primary indexed condition, and to 0 interventions.

NCT03770169 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, District of Columbia, Nebraska.

Frequently Asked Questions

What is clinical trial NCT03770169 about?

NCT03770169 is a clinical study titled "Validation of Patient Reported Outcome Measures for Use in Vulvodynia". The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia

What is the current status of trial NCT03770169?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-02-18. Estimated completion is 2019-09-19.

What conditions does trial NCT03770169 study?

This clinical trial studies the following conditions: Vulvodynia.

Who is sponsoring clinical trial NCT03770169?

This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03770169 being conducted?

This trial has 4 study locations across California, District of Columbia, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vulvodynia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vulvodynia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.